Australian Journal of General Practice
MSc (Biostats), Senior Health Economics Manager, Labcorp Drug Development, Macquarie Park, Sydney, NSW
Depot buprenorphine supported more than half of patients to remain in treatment, while allowing some flexibility in dose interval.